Page 27 - உயிரி தொழில்நுட்பவியல் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

EV Biologics Corporation: EV Biologics Confirms Funding to Commence Cell Line Generation & Advance Exosome Research NASHVILLE, TN / ACCESSWIRE / April 8, 2021 /?EV Biologics Corp (OTC PINK:YECO) today announced that it has signed a director s loan agreement to secure funding of up to $5 million to start generation of a novel exosome-producer cell line and production of therapeutic exosomes for preclinical research. The Company has finalized its preparation and is ready to begin generation of a novel exosome-producer master cell bank to enable manufacturing of therapeutic exosomes with improved intrinsic bioactivity at a commercially relevant scale. Our internal research indicates that this producer cell line and its derivatives will produce exosomes with native bioactivity superior to those manufactured using common producer cells, such as mesenchymal stem cells isolated from bone marrow, adipose tissue or umbilical cord, or exosomes found naturally in amniotic fluid.

United statesDaniel mckinneyDennis burnsExchange commissionEv biologics corporationEv biologics corpBiotechnology companyYulong eco materials limitedSecurities actஒன்றுபட்டது மாநிலங்களில்டேனியல் மகிநீடென்னிஸ் தீக்காயங்கள்பரிமாற்றம் தரகுஎவ் உயிரியல் நிறுவனம்எவ் உயிரியல் கார்ப்உயிரி தொழில்நுட்பவியல் நிறுவனம்